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Abstract
This study determined the prevalence and patterns of psychological symptoms in adolescents and young adults
living with HIV (YLWH) in medical care and relationships between psychological symptoms, route and
duration of infection, and antiretroviral treatment (ART). A clinic-based sample of 2032 YLWH (mean age 20.3
years), recruited from 20 adolescent medicine HIV clinics, completed a cross-sectional survey of health be-
haviors and psychological symptoms using the Brief Symptom Inventory (BSI). Overall, 17.5% of youth
reported psychological symptoms greater than the normative threshold on the Global Severity Index. A wide
variety of symptoms were reported. The prevalence of clinical symptoms was significantly greater in youth with
behaviorally acquired HIV compared to those with perinatally acquired infection (20.6% vs. 10.8%, OR= 2.06
in Multiple Logistic Regression (MLR)), and in those not taking ART that had been prescribed (29. 2% vs.
18.8%, OR= 1.68 in MLR). Knowing one’s HIV status for more than one year and disclosure of HIV status
were not associated with fewer symptoms. A large proportion of YLWH have psychological symptoms and the
prevalence is greatest among those with behaviorally acquired infection. The high rate of psychological
symptoms for youth not taking ART that is prescribed is a cause for concern. Symptoms do not appear to be a
transient reaction to diagnosis of HIV.
Introduction
HIV infection is disproportionately a disease ofadolescence, with individuals aged 16–24 years show-
ing the highest rate of new infections compared to other age
groups.1–3 Although there are a number of studies that doc-
ument the prevalence of psychological symptoms among
children living with HIV,4–7 there are fewer that address this
issue among adolescents, and none with a large cohort of
behaviorally infected youth in this era of simplified treatment
regimens. Examination of psychological symptoms and
emotional distress among adolescents living with HIV is
critical because they are associated with worse quality of
life,8,9 poorer health,8,10 less adherence to antiretroviral
medication (increasing the likelihood for secondary trans-
mission of HIV),11–14 greater substance use,6,15–17 and more
sexual risk behavior.6,16,18,19 For example, a study, using a
portion of the same data set used for this report, examined
1712 youth in care for HIV at fifteen adolescent medicine
HIV clinics and found one subgroup that was identified
through latent class analysis based on higher levels of sexual
risk and substance use. The group was also more likely to
report mental health concerns, less likely to be taking anti-
retroviral treatment (ART), and had higher viral loads com-
pared to those in the other groups.20
Despite indications that mental health disorders occur
frequently among adolescents and young adults living with
HIV (YLWH) and evidence of a contribution of emotional
distress to risk behaviors and health, to date little research has
been conducted on the prevalence and patterns of psycho-
logical symptoms among these youth. Six studies provide
quantitative data on the prevalence of significant, current
mental symptoms among YLWH. The studies used different
measures of psychological symptoms, and sample sizes were
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small, limiting the generalizability of the findings. Three
studies reported clinical diagnoses. Pao et al.21 conducted
structured clinical interviews with 34 YLWH (mean age 18.5
years) in an adolescent clinic and found that most had an Axis
1 diagnosis, commonly major depression (44%). Another
study examined 174 youth (mean age 21) in a HIV clinic and
found that 17% had an anxiety disorder and 15% a major
depressive disorder based on a clinical interview.22 In another
study, a computerized interview was used to screen specifi-
cally for depression in 147 young women living with HIV
(mean age 20.6 years) and found a rate of 10%.23 Two studies
report the prevalence of significant psychological symptoms
based on exceeding the threshold on standardized scales. In a
sample of 230 YLWH (mean age 16.1 years), 18% reported
elevated anxiety on the Children’s Manifest Anxiety Scale
and 17% elevated depression on the Child Depression In-
ventory.24 Among 166 YLWH (mean age 16.8 years), 21%
scored above the threshold for internalizing symptoms (e.g.,
depression, anxiety) and 30% for externalizing (e.g., conduct
problems) as measured by the Achenbach Youth Self Re-
port.25 A study with 66 YLWH found that 50% ‘‘scored
above the cutoff for significant mental health symptoms on
the Brief Symptom Inventory (BSI).’’26 Other studies have
administered the BSI to YLWH but have used the scale as
part of a correlation matrix or variable model.27–29 Mean
scores for the samples were not reported, so the prevalence of
clinically significant psychological symptoms cannot be de-
termined. In total, these studies suggest a substantial preva-
lence of psychological symptoms for youth living with HIV,
especially for symptoms of depression and anxiety. However,
these studies are limited by their small sample sizes and their
focus on only selected diagnoses or broad measures of
symptoms, such as internalizing or externalizing.
It is important to examine patterns of significant symptoms
reported by youth living with HIV in order to plan for
available treatments and to enhance screening efforts. In
addition, studies have not examined differences in symptoms
based on route of HIV acquisition. Several studies report on
psychological profiles of children or younger adolescents
with perinatally acquired HIV, but the patterns may change as
youth age and have access to medical and psychological
treatment. In addition, the extent and patterns of symptoms
may be different for those with behaviorally acquired HIV, as
some studies have demonstrated high rates of risk behaviors,
substance use, and psychological symptoms.15,18,19,30–32
It has been suggested that youth with behaviorally ac-
quired HIV progress through stages in their acceptance and
adaptation to the disease. An intense, emotional reaction is a
common initial response to learning of one’s infection,33
followed by a transition to acceptance of treatment,34 more
active coping with the disease,35 greater medical adher-
ence,11 and disclosure of infection to others.36 Hosek et al.37
have proposed an empirically-based ecological model of
stressors faced by youth during the first year of their HIV
diagnosis. The model describes a range of stressors that may
be confounded by the typical challenges of normal adolescent
development, and further exacerbated by living with a highly
stigmatized illness and, for some, the stigma of a non-
majority sexual orientation.38–41 Qualitative data demonstrate
that the initial period of acceptance after learning of one’s
infection is extremely challenging for youth as they reported
intense feelings of depression, isolation, and at times, suicidal
ideation.37 Acceptance of treatment, including ART, coin-
cides with fewer psychological symptoms. Youth with peri-
natal infection have known of their infection and have been
engaged with healthcare longer, on average, than those with
behaviorally acquired HIV. The greater length of time to
adjust to the diagnosis and to receive health services should
be associated with fewer psychological symptoms. Although
there is some evidence for these associations,4,9,16,17,30 they
have not been verified in a large and diverse sample.
A greater understanding of the psychological symptoms
among youth served by the clinics would enable the devel-
opment of more targeted programs for YLWH. This article
examines cross-sectional survey data from a large scale,
multi-site study in a population of YLWH who were re-
ceiving clinic-based medical care in order to describe and
compare the extent and patterns of psychological symptoms
reported by youth based on method of acquisition of HIV
(behavioral vs. perinatal).
It was hypothesized that significant psychological symp-
tomswould bemore prevalent among those with behaviorally
acquired HIV than in those with perinatally acquired HIV
because of factors described above and that symptoms would
be more prevalent among males with a non-majority sexual
orientation. Because of the stress associated with receiving a
HIV diagnosis, it was hypothesized that more psychological
symptoms would be found in the first year after learning of
one’s diagnosis.
Psychological symptoms were hypothesized to be a barrier
to disclosure of HIV by the youth to others and be greater
among those who had been prescribed ART but were not
taking it. Data on the complex multifactorial relationships
between mental health symptoms, risk behaviors (sexual and
substance use), medication adherence, and health indices will
be reported in subsequent publications.
Methods
Participants
Location of recruitment. From December 2009 through
January 2012, youth living with HIV or AIDS were recruited
from 20 adolescent medicine clinics that provide a range of
services to YLWH and are part of the Adolescent Medicine
Trials Network for HIV/AIDS Interventions (ATN) to par-
ticipate in a cross sectional survey. Sites are listed in the
acknowledgements.
Eligibility criteria. To be eligible, youth had to be: (1) 12
through 24 years of age; (2) living with HIV/AIDS; (3) aware
of their HIV positive status; (4) engaged in care in one of the
ATN’s adolescent medicine treatment units or affiliates; and
(5) able to understand English or Spanish.
Consenting procedures. Youth were recruited at 20 ad-
olescent medicine treatment units (ATMUs) that were a part
of the ATN between 2009 and 2012. Research staff ap-
proached all youth meeting eligibility criteria during one of
their regularly scheduled clinic visits to describe the study.
After a thorough explanation of the study and its procedures,
staff obtained signed informed consent from all youth who
agreed to participate. In cases where parental consent was
needed, youth assent was obtained after parental consent was
given.
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Study procedures and final sample size. The 20 sites
obtained informed consent from 2216 participants.
Screening data was available from 18 of the sites, which
enrolled 91% of the participants. Those 18 sites screened
2325 patients and 95% were eligible. 91% of the eligible
subjects were enrolled. 2032 of the available 2216 surveys
from all 20 sites had data on the Brief Symptom Inventory
(the key outcome variable for this study), and data for
gender and route of transmission (primary predictor vari-
ables). These 2032 surveys comprised the sample used for
analysis. A 45-min audio-computer assisted self-interview
(A-CASI) was followed by a 5-min debriefing interview.
The encrypted A-CASI data was transferred to the ATN
Data Coordination Center secure website without any per-
sonally identifiable participant information. The procedures
were approved by the Institutional Review Boards at each
participating site as well as those from the members of the
protocol team. Participants were given a small compensa-
tion determined by each site’s IRB for their time and effort.
Sites did not have access to any of the participants’ re-
sponses to the A-CASI.
Psychosocial assessment
The psychosocial assessment was designed to assess sev-
eral domains. The following measures, which took a total of
10–15min to complete, were used in this analysis. Other
domains (medical adherence, sexual and substance risk,
health indices) will be reported in other publications.
Demographic and HIV-related variables. Age, birth gen-
der, race and ethnicity, self-identified route of infection with
HIV (How do you think you got HIV? Perinatal = ‘‘I was born
with it’’; Behavioral = ‘‘sex with a man, sex with a woman,
injection drug use’’), time since knowledge of HIV status
( > 1 year, £ 1 year), sexual orientation (‘‘straight, gay, les-
bian, queer, bisexual, questioning’’), refusal of ART (‘‘Has
your doctor offered or prescribed pills or other medicines
for your HIV infection but you never took them?’’ Yes/No),
and disclosure of HIV infection to others (‘‘disclosed HIV to
anyone?’’ Yes/No) were collected.
Mental health. The Brief Symptom Inventory (BSI) was
used to assess mental health issues.42 The BSI is a 53 item
measure that yields nine primary symptom subscales (see
Table 2) and a Global Severity Index (GSI). Symptom sub-
scales include: Somatization, Obsessive-Compulsive, Inter-
personal Sensitivity, Depression, Anxiety, Hostility, Phobic
Anxiety, Paranoid Ideation, and Psychoticism. Items have the
following response options: not at all (0), a little bit (1),
moderately (2), quite a bit (3), extremely (4). Internal con-
sistency for the subscales (dimensions) ranged from 0.71 to
0.85. The Global Severity Index combines information about
number of symptoms and intensity of distress and has often
been used as a measure of general psychological distress and
symptomatology.26,42 The internal consistency of the GSI has
been reported as 0.98.43
Data analysis
Because the BSI has separate norms for males and females,
separate analyses were run for each gender. Differences be-
tween groups were examined using t-tests for BSI subscale
scores and chi-square tests for the proportion of youth above
the threshold of the BSI norms (T score > 63) for being
‘‘considered a positive case.’’44 Symptoms greater than the
threshold will be termed ‘‘clinically significant’’ for this re-
port, although establishing a diagnosis is beyond the scope of
any screening instrument. Because the mean age of the
sample was 20.3 years, adolescent norms were used since the
adult norms are based on a sample with a mean age of 46
years. When age was significantly different between groups
to be compared, an ANCOVA was used, rather than a t-test,
to control for age. Finally, the association of the GSI of the
BSI with variables found to be significant in univariate
comparisons was examined using logistic regression. SPSS
version 15.0 was used to analyze the data.
Results
Description of sample
Of the 2032 YLWH whose data was analyzed for this re-
port, 1370 were males (67% of total) and 662 were females
Table 1. Demographic Characteristics of Participants
Sample Perinatal Behavioral
% or M N or SD % or M N or SD % or M N or SD X2 or t p
Gender 209.80 < 0.001
Male 67.4% 1370/2032 44.9% 282/628 77.5% 1088/1404
Female 32.6% 662/2032 55.1% 346/628 22.5% 316/1404
Ethnicity 0.002 0.952
Hispanic 19.4% 392/2025 19.4% 121/623 19.3% 271/1402
None Hispanic 80.6% 1633/2025 80.6% 502/623 80.7% 1131/1402
Race 0.795 0.977
Asian/Pacific Islander 1.0% 21/2014 0.8% 5/615 1.1% 16/1399
Black/African American 68.2% 1374/2014 68.0% 418/615 68.3% 956/1399
Native American 0.9% 19/2014 0.8% 5/615 1.0% 14/1399
White 12.8% 258/2014 12.8% 79/615 12.8% 179/1399
Mixed 10.7% 216/2014 11.1% 68/615 10.6% 148/1399
Other 6.3% 126/2014 6.5% 40/615 6.1% 86/1399
Age 20.25 2.14 18.10 2.93 21.22 2.04 27.66 < 0.001
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(33%) with a mean age of 20.3 years. The sample was pre-
dominantly racial/ethnic minority, with 68.2% identify-
ing racially as black/African American, 12.8% white, and
10.7% Mixed (Table 1). Ethnically, 19.4% identified as
Hispanic/Latino. The most frequently reported route of HIV
infection for males was from ‘‘sex with a man’’ (74.1%),
followed by perinatal infection (20.1%). Women most fre-
quently reported their route of HIV infection as perinatal
infection (50.6%), followed by ‘‘sex with a man’’ (47.0%).
Of those with behaviorally acquired infection, 45.1% had
been diagnosed with HIV infection within the last 12 months.
Of the 2032 participants, 17.5% reported symptoms
greater than the threshold to be considered significant on the
GSI, with 20.6% of youth with behavioral infection and
10.8% of those with perinatal infection reporting clinically
significant symptoms ( >T score of 63). Table 2 reports the
proportion of youth above the BSI thresholds for each sub-
scale by route of infection for males and females. A greater
proportion of youth with above threshold symptoms was
found among those with behavioral infection on most sub-
scales. There were no differences among the males with be-
havioral infection based on sexual orientation (heterosexual
vs. nonheterosexual) [data not shown].
Those who were behaviorally infected were significantly
older [21.2 (SD = 2.04)] for behaviorally infected vs. 18.1
(SD = 2.92) for perinatally infected, t= 27.66, p < 0.001, so
age was controlled in the subsequent analyses. Table 3 shows
the mean BSI subscales scores for the four groups. For males,
those with behavioral HIV infection were significantly more
likely to report symptoms on each of the ten scales. Among
males with behavioral infection, the only difference based on
sexual orientation was that those with a heterosexual orien-
tation reported more paranoid symptoms [7.45 (5.33) vs. 6.43
(5.06) F = 4.50, p= 0.034; other data not shown]. For females,
the behavioral group, compared to the perinatal, reported
more symptoms for eight of the ten scales (except depression
and phobic anxiety, p > 0.05).
Chi-square analyses (Table 4) found that in the behav-
iorally infected group there was a greater proportion of
youth with significant mental symptoms among those not
taking ART that had been prescribed (29.2% vs. 18.8%)
but this difference was not found in the perinatal group.
Also, length of time knowing one’s HIV status and dis-
closureof HIV status were not associated with psycho-
logical symptoms.
A multiple logistic regression (MLR) examined the asso-
ciation of clinically significant GSI scores with age, route of
transmission, and not taking ART that was prescribed (Table
5). Because most males with behavioral transmission were
nonheterosexual, only the transmission category was entered
into the regression to avoid multicolinearity. Gender was not
entered because it was not associated with GSI scores. The
odds of having a clinically significant GSI score were sig-
nificantly greater for those with behavioral transmission
Table 2. Proportion of Youth Living with HIV Above Thresholds
on Subscales the Brief Symptom Inventory
Males
Perinatal transmission Behavioral transmission
(% above threshold) (% above threshold)
N = 282 N= 1088 X2 p
Global Severity Index 6.6 19.8 25.39 < 0.001
Anxiety 4.0 17.6 32.32 < 0.001
Somatization 4.7 15.8 23.26 < 0.001
Obsessive compulsive 11.5 22.6 16.90 < 0.001
Depression 7.9 23.8 34.17 < 0.001
Hostility 6.4 14.5 13.20 < 0.001
Phobic anxiety 4.3 15.7 24.93 < 0.001
Paranoid 8.2 19.4 19.66 < 0.001
Psychoticism 11.3 21.6 14.70 < 0.001
Interpersonal sensitivity 5.1 18.1 28.90 < 0.001
Females
Perinatal transmission Behavioral transmission
(% above threshold) (% above threshold)
N = 346 N = 316 X2 p
Global Severity Index 14.2 23.2 8.49 0.004
Anxiety 6.1 16.0 16.35 < 0.001
Somatization 16.8 25.8 8.0 0.005
Obsessive compulsive 16.4 25.8 8.68 0.003
Depression 17.8 24 3.81 0.051
Hostility 15.0 21.2 4.26 0.039
Phobic anxiety 12.6 18.8 4.75 0.029
Paranoid 21.2 24.5 1.02 0.313
Psychoticism 12.4 26.3 20.34 < 0.001
Interpersonal sensitivity 14.7 20.2 3.36 0.067
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(OR = 2.06) and those not taking ART that was prescribed
(OR = 1.68), while controlling for age in the MLR.
Discussion
This study is the largest report to date of the psychological
symptoms of YLWH who are in care. Overall, 18% of youth
reported symptoms beyond the threshold considered clini-
cally significant for the BSI, compared to 10–50% reported
in previous studies.21–26 The rate of 18% may be a more
accurate estimate of clinically significant symptomatology
because prior studies have been limited by smaller and less
diverse samples. In addition, there was no distinct pattern to
the symptoms reported. For example, youth were as likely to
experience hostility as they were anxiety or depression. This
wide range of symptomatology suggests that health care
providers need to be alert to the full spectrum of emotional
and behavioral problems with which youth may present and
have appropriate interventions available. It also suggests that
even though behavioral acquisition of HIVmay be associated
with impulsive, risky behaviors, such as unsafe sex and
substance use, many youth may be withdrawn and distressed.
YLWH with behaviorally acquired infection, compared to
those with perinatal infection, had twice the odds (21% vs.
11%, OR = 2.06 in MLR) of reporting clinically significant
psychological symptoms. It is possible that greater access
Table 3. Mean Subscale Scores on the Brief Symptom Inventory Among Youth Living with HIV
Males
Perinatal transmission Behavioral transmission
N = 282 N = 1088 Fa p
Global Severity Index 0.65 1.04 36.13 < 0.001
Anxiety 0.45 0.88 32.08 < 0.001
Somatization 0.47 0.81 26.70 < 0.001
Obsessive compulsive 0.93 1.17 8.57 0.003
Depression 0.64 1.17 33.25 < 0.001
Hostility 0.85 1.13 20.03 < 0.001
Phobic anxiety 0.34 0.66 22.53 < 0.001
Paranoid 0.95 1.31 23.50 < 0.001
Psychoticism 0.63 1.03 22 < 0.001
Interpersonal sensitivity 0.59 1.12 41.26 < 0.001
Females
Perinatal transmission Behavioral transmission
N = 346 N = 316 Fa p
Global Severity Index 0.86 1.05 11.01 0.001
Anxiety 0.61 0.77 6.44 0.011
Somatization 0.63 0.84 11.5 0.001
Obsessive compulsive 1.05 1.16 4.34 0.038
Depression 0.96 1.16 3.34 0.068
Hostility 1.01 1.18 10.69 0.001
Phobic anxiety 0.53 0.62 3.08 0.080
Paranoid 1.21 1.39 8.97 0.003
Psychoticism 0.77 1.06 16.53 < .001
Interpersonal sensitivity 0.99 1.14 5.76 0.017
aANCOVA controlling for Age
Table 4. Association of Global Severity Index Scores with ART Refusal, Having Disclosed
HIV Status, and Time Knowing HIV Status
Transmission group Variable GSI elevated (%) X2 p
Perinatal ART refusal—Yes 10/76 (13.2%) 0.468 0.494
–No 53/503 (10.5%)
Behavioral ART refusal—Yes 209/1109 (18.8%) 12.31 < 0.001
–No 66/226 (29.2%)
Perinatal Have disclosed—Yes 45/379 (11.9%) 1.25 0.264
–No 16/183 (8.7%)
Behavioral Have disclosed—Yes 245/1175 (20.9%) 0.377 0.539
–No 31/165 (18.8%)
Behavioral Time knowing HIV status £ 1 year 130/602 (21.6%) 0.664 0.415
> 1 year 145/733 (19.8%)
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over time to medical and psychological treatment by those
with perinatal infection accounts for their reduced risk. In
fact, the prevalence of 10.8% among youth with perinatally
acquired HIV is very close to rates found in community
samples without specific health conditions and suggests a
generally successful adaptation to illness for this group.42 In
the group with behaviorally acquired infection, HIV is con-
tracted by risk behaviors that may be associated with psy-
chological symptoms, which could account for that group’s
greater report of symptoms. Further, symptoms in this group
were no less prevalent in those who had known of their in-
fection for more than one year as compared to newly diag-
nosed youth. Thus, the passage of time and the initial access
to care and psychological treatment in clinics does not di-
minish the prevalence of psychological concerns among
youth.
In HIV treatment clinics, ART has become widely used,
and is used earlier in the course of infection. Indeed, 83% of
the participants with behaviorally acquired HIV were taking
ART. Unfortunately, the odds was two-thirds greater of re-
porting clinically significant psychological symptoms (29%
vs. 19%, OR = 1.68 in MLR) among those not taking ART
that was prescribed compared to those taking medication,
even when accounting for the impact of age and route of
transmission. Several factors could account for this finding,
either independently or in concert. It is possible that mental
health issues preclude some youth from considering taking
medications or providers are more reluctant to prescribe
them. It is also possible that some youth begin on ART
treatment and their mental health improves in parallel to their
physical health. No matter the cause, health care providers
should be particularly alert to mental health concerns of those
not on ART because of the increased risk of transmission and
the potential for psychological symptoms to reduce their
quality of life.
Those who had disclosed their HIV infection to others
were just as likely to report psychological symptoms as those
who had not. Several factors related to disclosure were not
examined in this study, such as the number of people told, the
quality of the relationships, and the perceived outcome of
disclosure. These important factors could interact with
mental health issues.45 In any case, the act of disclosure is not
a guarantee of fewer mental health concerns.
This study has several limitations. The study examined
cross-sectional data that were collected at one point in time
and thus causal relationships cannot be identified. These data
cannot determine changes that may occur in mental health as
individuals live with and manage their HIV infection. The
measure of psychological symptoms was a self-report
screening tool, rather than structured psychiatric diagnosis
derived from a clinical interview. However, the BSI has been
widely used and assesses a wide range of emotional and
behavioral symptoms. Most information was obtained via
self-report and thus can be inaccurate. Efforts were made,
however, to increase accurate reporting by means such as the
use of confidential computer assisted administration. One
recent study in the ATN found that the use of computer as-
sisted self-reporting of drug use had high rates of concor-
dance with toxicology results in youth with HIV infection.46
Finally, all participants are currently receiving some type of
medical or psychosocial care through adolescent medical
care clinics. Thus, youth with HIV infection who are not
engaged in the medical system are not represented in this
sample. It is possible that these youth may have different
patterns of psychological symptoms from those identified in
this study.
In summary, this study presents data on the prevalence and
correlates of psychological symptoms among one of the
largest samples of adolescents and young adults with HIV
infection who are receiving medical care drawn nationally
from 20 different sites across the country. The results of this
study suggest that a significant number of youth are troubled
by mental health issues and the prevalence is greatest among
those with behaviorally acquired infection. Psychological
symptoms of all types are reported ranging from depression
and anxiety to hostility and paranoia. Symptoms are not
fewer if individuals have known of their infection longer or
have disclosed their infection to others. Adjustment to living
with HIV is a complex process and each new event, such as
disclosure, may relieve some issues and bring others into
focus. The small proportion of youth not taking ART that had
been prescribed had very high rates of psychological symp-
toms and is a cause for concern, given the increased chance of
HIV transmission with greater viral loads and the decreased
quality of life with more mental health issues. Engaging these
youth in psychiatric treatment is critical and may require
multiple, innovative approaches that are tailored for each
person. It is left to future research to examine these patterns
of psychological symptoms over time in adolescents and
young adults living with HIV. Symptoms need to be exam-
ined in relation to the many important, changing, factors in
the lives of youth such as their engagement in care, health
status, substance use, employment, housing status, and
available social supports.45,47 It is likely that programs will
need to acknowledge the relevance of all of these factors in
order to adequately address the mental health concerns of the
youth whom they serve.
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